Blossomhill Therapeutics, Inc. · NASDAQ:BLSM
Vivo Innovation Fund II Holdings, L.P. reported a 5.50% stake in Blossomhill Therapeutics, Inc. (Schedule 13G)
Event Aug 10, 2026 · Filed Aug 17, 2026
Vivo Innovation Fund II Holdings, L.P. reported a 5.50% stake in Blossomhill Therapeutics, Inc., 1,681,240 shares, as a passive investor on Aug 10, 2026. Filed Aug 17, 2026 (Schedule 13G).
- Stake
- 5.50%
- Shares
- 1,681,240
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vivo Innovation Fund II Holdings, L.P. | 5.50% | 1,681,240 |
| Vivo Innovation II, LLC | 5.50% | 1,681,240 |
Source
Related
- Blossomhill Therapeutics, Inc.
- Vivo Innovation Fund II Holdings, L.P.
- Blossomhill Therapeutics, Inc. shareholders
- Schedule 13D · Orbimed Advisors LLC · Aug 18, 2026
- Schedule 13G · Perceptive Advisors LLC · Aug 14, 2026
- Schedule 13D · Chen Bihua · Aug 13, 2026
- Form 4 · Gordon Carl L · Aug 12, 2026
- Form 4 · OrbiMed Capital GP VIII LLC · Aug 12, 2026